Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Doonyapat Sa-nguanraksa"'
Autor:
Suyanee Thongchot, Krittaya Aksonnam, Jaturawitt Prasopsiri, Malee Warnnissorn, Doonyapat Sa-nguanraksa, Pornchai O-Charoenrat, Peti Thuwajit, Pa-thai Yenchitsomanus, Chanitra Thuwajit
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-20 (2024)
Abstract Background Triple-negative breast cancer (TNBC), known for its aggressiveness and limited treatment options, presents a significant challenge. Adoptive cell transfer, involving the ex vivo generation of antigen-specific T cells from peripher
Externí odkaz:
https://doaj.org/article/541e33883a9746f09090f1d15e1eeb00
Autor:
Monthira Suntiparpluacha, Jantappapa Chanthercrob, Doonyapat Sa-nguanraksa, Juthamas Sitthikornpaiboon, Amphun Chaiboonchoe, Patipark Kueanjinda, Natini Jinawath, Somponnat Sampattavanich
Publikováno v:
PeerJ, Vol 11, p e15350 (2023)
Background Triple-negative breast cancer (TNBC) is a rare and aggressive breast cancer subtype. Unlike the estrogen receptor-positive subtype, whose recurrence risk can be predicted by gene expression-based signature, TNBC is more heterogeneous, with
Externí odkaz:
https://doaj.org/article/22a3104897434dce94af55093751b24f
Autor:
Chanitra Thuwajit, Pa-thai Yenchitsomanus, Peti Thuwajit, Pornchai O-Charoenrat, Doonyapat Sa-nguanraksa, Nisa Chuangchot, Wannasiri Chiraphapphaiboon, Piriya Luangwattananun, Niphat Jirapongwattana, Suyanee Thongchot
Dendritic cell (DC)–based T-cell activation is an alternative immunotherapy in breast cancer. The anti-programmed death ligand 1 (PD-L1) can enhance T-cell function. Nucleolin (NCL) is overexpressed in triple-negative breast cancer (TNBC). The regu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58652b016c49d696f95ef278fe021b85
https://doi.org/10.1158/1535-7163.c.6543246.v1
https://doi.org/10.1158/1535-7163.c.6543246.v1
Autor:
Chanitra Thuwajit, Pa-thai Yenchitsomanus, Peti Thuwajit, Pornchai O-Charoenrat, Doonyapat Sa-nguanraksa, Nisa Chuangchot, Wannasiri Chiraphapphaiboon, Piriya Luangwattananun, Niphat Jirapongwattana, Suyanee Thongchot
Supplementary Figure from Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c782fdbc4598f95ed40a2189b8d92dd
https://doi.org/10.1158/1535-7163.22521987
https://doi.org/10.1158/1535-7163.22521987
Autor:
Chanitra Thuwajit, Pa-thai Yenchitsomanus, Peti Thuwajit, Pornchai O-Charoenrat, Doonyapat Sa-nguanraksa, Nisa Chuangchot, Wannasiri Chiraphapphaiboon, Piriya Luangwattananun, Niphat Jirapongwattana, Suyanee Thongchot
Supplementary Data from Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e6db8f5d1c82ccf1018438c12e8d8f
https://doi.org/10.1158/1535-7163.22521999
https://doi.org/10.1158/1535-7163.22521999
Autor:
Suyanee Thongchot, Niphat Jirapongwattana, Piriya Luangwattananun, Wannasiri Chiraphapphaiboon, Nisa Chuangchot, Doonyapat Sa-nguanraksa, Pornchai O-Charoenrat, Peti Thuwajit, Pa-thai Yenchitsomanus, Chanitra Thuwajit
Publikováno v:
Molecular Cancer Therapeutics. 21:727-739
Dendritic cell (DC)–based T-cell activation is an alternative immunotherapy in breast cancer. The anti-programmed death ligand 1 (PD-L1) can enhance T-cell function. Nucleolin (NCL) is overexpressed in triple-negative breast cancer (TNBC). The regu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b32c5af56e822f6816555efd692e00
https://doi.org/10.1158/1535-7163.mct-21-0823
https://doi.org/10.1158/1535-7163.mct-21-0823
Autor:
Doonyapat Sa-nguanraksa, Norasate Samarnthai, Thanawat Thumrongtaradol, Pornchai O-charoenrat, Kwanlada Mitpakdi
Publikováno v:
Gland Surg
BACKGROUND: Breast cancer is the most frequent female malignancy in Thailand. Prolactin (PRL) and prolactin receptor (PRLR) play an important role in normal breast development and carcinogenesis of breast cancer. There are two major isoforms of PRLR,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b60fe272e46ca2f45cf54e53d2a29280
https://doi.org/10.21037/gs-20-569
https://doi.org/10.21037/gs-20-569
Autor:
Niphat Jirapongwattana, Suyanee Thongchot, Wannasiri Chiraphapphaiboon, Thaweesak Chieochansin, Doonyapat Sa‑Nguanraksa, Malee Warnnissorn, Peti Thuwajit, Pa-Thai Yenchitsomanus, Chanitra Thuwajit
Publikováno v:
Oncology reports. 48(1)
Triple negative breast cancer (TNBC) lacks targeted treatment resulting in poor prognosis. Targeting overexpressing mesothelin (MSLN) using MSLN‑specific T cells is an attractive treatment approach and the aim of the present study. The expression o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e9c54eba610f98d421c735cba4611b
https://pubmed.ncbi.nlm.nih.gov/35616135
https://pubmed.ncbi.nlm.nih.gov/35616135
Autor:
Pornchai O-charoenrat, Doonyapat Sa-nguanraksa, Norasate Samarnthai, Thanawat Thumrongtaradol, Cholladda Thasripoo, Tanawan Kummalue
Publikováno v:
Translational Cancer Research. 9:6344-6353
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::716c874c3f45688dc4c49f20f684daa8
https://doi.org/10.21037/tcr-20-1120
https://doi.org/10.21037/tcr-20-1120
Autor:
Nuanphan Polchai, Doonyapat Sa-nguanraksa, Thanawat Thumrongtaradol, Warapan Numprasit, Pornchai O-charoenrat, Eng O-charoenrat
Publikováno v:
Cancer Management and Research. 12:5549-5559
Background and Purpose Web-based prognostic calculators have been developed to inform about the use of adjuvant systemic treatments in breast cancer. CancerMath and PREDICT are two examples of web-based prognostic tools that predict patient survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e407673d1745baf0396c853c967e2c8f
https://doi.org/10.2147/cmar.s258143
https://doi.org/10.2147/cmar.s258143